Insmed (NASDAQ:INSM) had its price target lowered by analysts at Mizuho from $211.00 to $204.00. They now have an "outperform" rating on the stock.
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE [Yahoo! Finance]
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $230.00 price target on the stock.
Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says [Yahoo! Finance]
Insmed (NASDAQ:INSM) was given a new $166.00 price target on by analysts at Morgan Stanley.